Grown Rogue International Inc. (GRIN) Earnings Call Transcripts
Grown Rogue International Inc.'s Latest Earnings Call - April 7, 2026
In the full year 2025 earnings call, Grown Rogue International Inc. (GRIN:CA) reported a strong focus on growth and expansion, particularly in New Jersey and the upcoming Minnesota market. Revenue guidance for Q1 2026 indicates a projected double-digit growth compared to Q1 2025, signaling potential upward momentum for the stock. The company also highlighted significant operational improvements and strategic hires aimed at enhancing its market presence and production capacity, with a forecasted increase in flowering capacity by over 50% in 2026.
Reported metrics
| Metric | Value |
|---|---|
| Revenue Growth | double-digit growth (positive) |
| Flowering Capacity Increase | 21,000 square feet (positive) |
| Production Cost | below $225 per pound (positive) |
| Debt Facility | $12 million (positive) |
| Growth Targets | 25% revenue growth, 35% profit growth (positive) |
| Market Expansion | 5 states operational by end of '26 (positive) |
Guidance from management
Management expects double-digit revenue growth in Q1 2026 compared to Q1 2025 and aims to achieve significant capacity increases through ongoing expansions in New Jersey and Minnesota.
What management said
Okay. Great. Yes, just in summary, thanks, everyone, for joining. Looking forward to '26. And yes, not repeating the IFRS to GAAP transition again. I know the accounting finance team will be happy with that. But yes, looking forward to an exciting '26 and appreciate everyone joining and listening to the Grown Rogue story.
What analysts pressed on
Analysts expressed concerns regarding the ongoing pricing pressures in Oregon and Michigan, questioning how these factors might impact future profitability. There were also inquiries about the timeline for new market activations and the potential risks associated with expansion.
Main topics on the call
- Expansion into New Markets — Grown Rogue is set to expand into Minnesota, with construction already underway and a target completion date in Q3 2026. Management stated, "We're targeting 8,000 to 8,500 square feet of flowering canopy in Phase 1," ind...
- Operational Improvements — The company is focusing on enhancing production efficiency, with a goal to reduce costs. Management noted, "We expect to see our cost of production continue to go down," which is critical for maintaining competitiveness.
- Brand Strategy and Market Positioning — Grown Rogue emphasized the importance of brand differentiation in new markets, particularly with the launch of its value brand, Yeti. Management remarked, "It's just been nice to see that sell-through and that adoption i...
- Financial Guidance and Growth Targets — Management provided ambitious long-term growth targets, aiming for 25% compound revenue growth and 35% compound profit growth. They stated, "We see the opportunity for us to be a much larger, profitable company in our fu...
Read the full Grown Rogue International Inc. transcript (April 7, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Grown Rogue International Inc.
Grown Rogue International Inc. (GRIN) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on CNSX and is based in CA. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 3 calls on record spanning April 7, 2026 to August 4, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 3 Grown Rogue International Inc. earnings call transcripts on record, spanning April 7, 2026 to August 4, 2026. Based on this history, Grown Rogue International Inc. reports quarterly. The most recent call on file is dated August 4, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- GRIN
- Exchange
- CNSX
- Country
- CA
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Calls on record
- 3
- First call
- April 7, 2026
- Most recent
- August 4, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Q2 FY2026 | Aug 4, 2026 | Read transcript → |
| Q1 FY2026 | May 12, 2026 | Read transcript → |
| Earnings Calls | Apr 7, 2026 | Read transcript → |